US61775R1059 - Common Stock
MORPHIC HOLDING INC
NASDAQ:MORF (5/17/2024, 7:14:11 PM)
After market: 29.23 0 (0%)29.23
-3.22 (-9.92%)
Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. The company is headquartered in Waltham, Massachusetts and currently employs 102 full-time employees. The company went IPO on 2019-06-27. The firm is engaged in discovering and developing a pipeline of oral small molecule integrin therapeutics for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. The firm's Morphic integrin technology platform (MInT Platform) helps to develop novel product candidates designed to achieve the potency, high selectivity, and pharmaceutical properties required for oral administration. The firm is advancing its pipeline, including its lead product candidate, MORF-057, which is an a4b7-specific integrin inhibitor affecting inflammation, into clinical development for the treatment of inflammatory bowel disease (IBD). The firm has also developed selective oral αvβ6-specific integrin inhibitors for the treatment of fibrotic diseases, including idiopathic pulmonary fibrosis.
MORPHIC HOLDING INC
35 Gatehouse Drive A2
Waltham MASSACHUSETTS 02451
P: 17819960955
CEO: Praveen P. Tipirneni
Employees: 102
Website: https://morphictx.com/
MORF stock results show that Morphic Holding beat analyst estimates for earnings per share the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Morphic Holding (NASDAQ:MORF) just reported results for the first quarter of 20...
MORF ends 1Q24 with $659 million, cash into 2H27; phase 2b study of MORF-057 in UC continues on target; anticipate GARNET phase 2 in Crohn's to begin 2Q...
/PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Morphic (NASDAQ: MORF). The investigation results from inaccurate...
Here you can normally see the latest stock twits on MORF, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: